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Completed HPV vaccination rates in two distinct populations 
of New Jersey 
James Cahill, MS4, Dr. Stacey Hammer, MD, Dr. Nicole Leopardi, MD
Abstract
In accordance with updated CDC guidelines from 
2018, the vaccination schedule for HPV varies 
according to the age of the patient, most critically 
by allowing for two injections instead of three if 
the process began prior to turning 15 years old. In a 
previous study, it was shown that suburban practice 
location was associated with higher completion 
rates of the HPV vaccine (Chou et. All 2011). By 
gathering data from Camden and Moorestown 
offices within Cooper Pediatrics, we could evaluate 
this assertion within southern New Jersey and 
further evaluate if there was a difference in 
completion rates by age groups. Using a 
retrospective chart review of 320 patients’ data and 
using chi-square analysis, it was determined there 
was significant statistical difference in vaccine 
series completion between the two offices and by 
age group. 
Methods & Results
This study gathered data from 160 patients from Moorestown and 160 
from Camden (80 9-14-year-old and 80 15+ year old from each 
location.)  This is based on historical data of 40% completion in 
Caucasian populations and 25% in minority populations with a power 
of 80% and alpha of 0.05. Using a chi-square analysis, the compiled 
data was analyzed (shown in four charts in center of poster). 
Significant difference in the groups was based on p<.05. The degrees 
of freedom was 1. 
Comparing 9-14-year-old patients from each location, no significant 
difference was discovered (P-value is 0.59816). It was found that the 
Moorestown location had a significantly higher amount of vaccination 
series completions compared to Camden when the series began after 
15 years old (P-value is 0.000016 ). When comparing all patients in 
Moorestown and Camden, Moorestown patients completed 
vaccination series at a significantly higher rate (P-value is 0.000242). 
Additionally, the completion rate was significantly higher when the 
inoculation began prior to 15 years of age (P-value is <0.00001).
Conclusion
Compared to trends seen in other studies, the data analyzed here 
shows a significantly higher completion of vaccine series in a 
suburban (Moorestown) population compared to inner-city (Camden). 
While the data compiled did not include a patient’s race, historical 
data has shown lower rates of completion in minority populations and 
could be a data point for comparison in the future (Kester et. All 
2013).  A potential for further insight would be a questionnaire to 
gather thoughts pertaining to vaccines overall and the HPV vaccine 
specifically due to a potential perceived connection with sexual 
activity. The differences in vaccination rates of males and females 
could be another data point. South New Jersey has access to rural 
populations as well, which could provide additional access and insight 
to large groups of people that often have sub-standard level of access 
to healthcare (Mead 2019).  
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Purpose
Inoculation with HPV vaccine provides a direct 
benefit to recipients by safely protecting against 
cancers that can result from persistent HPV 
infection. This preventive effect is most notable and 
best studied with cervical cancer in females, which 
is one of the most common female cancers 
worldwide. By conducting analysis of vaccination 
rates, we can monitor trends in completion with 
less required follow-ups if treatment begins at an 
earlier age. Additionally, with more information we 
can better educate our patients and their family 
members about the benefits of beginning this 
process earlier, as the the vaccine works best before 
any initial exposure to HPV (CDC 2019). 
Introduction
